PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Prestige Consumer Healthcare's PE Ratio without NRI is 16.72. Prestige Consumer Healthcare's 5-Year EBITDA growth rate is -30.90%. Therefore, Prestige Consumer Healthcare's PEG Ratio for today is N/A.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Prestige Consumer Healthcare's PEG Ratio or its related term are showing as below:
During the past 13 years, Prestige Consumer Healthcare's highest PEG Ratio was 16.23. The lowest was 0.47. And the median was 1.34.
PBH's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.63 * Ranked among companies with meaningful PEG Ratio only.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Prestige Consumer Healthcare PEG Ratio Historical Data
The historical data trend for Prestige Consumer Healthcare's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prestige Consumer Healthcare PEG Ratio Distribution
For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Prestige Consumer Healthcare's PEG Ratio falls into.
Prestige Consumer Healthcare PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
Prestige Consumer Healthcare's PEG Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Prestige Consumer Healthcare (NYSE:PBH) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Prestige Consumer Healthcare PEG Ratio Related Terms
Thank you for viewing the detailed overview of Prestige Consumer Healthcare's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Prestige Consumer Healthcare (Prestige Consumer Healthcare) Business Description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBH has been successfully added to your 